Research
Metabolic adaptation
Insulin users incur at least double the one-year T2D-HE compared to non-users within each BMI category.
Insulin therapy significantly increases healthcare costs for patients with type 2 diabetes.
StrongSupportsmedium confidence
Within each BMI category, insulin users' one‐year T2D‐HE was at least double that of non‐users.
Why this rating
Based on a large retrospective analysis of patient data.
Source
Body mass index and insulin use as identifiers of high‐cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data
Stephen S. Johnston et al. · Diabetes Obesity and Metabolism · 2019
DOI 10.1111/dom.13671
cohort · n=13026Cited 5×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- BMI and insulin use are jointly associated with one-year follow-up type 2 diabetes-related healthcare expenditures (T2D-HE), ranging from $5842 in overweight patients with no insulin to $17,700 in OCIII insulin users.Strong
- Obese class III (OCIII) insulin users incur the greatest annual healthcare expenditures among the studied population.Strong
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →